Lactoferrin-tethered betulinic acid nanoparticles promote rapid delivery and cell death in triple negative breast and laryngeal cancer cells

Cancer management presents multifarious problems. Triple negative breast cancer (TNBC) is associated with inaccurate prognosis and limited chemotherapeutic options. Betulinic acid (BA) prevents angiogenesis and causes apoptosis of TNBC cells. NIH recommends BA for rapid access in cancer chemotherapy...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Asim Halder, Megha Jethwa, Pritha Mukherjee, Subarna Ghosh, Suvadra Das, A. B. M. Helal Uddin, Arup Mukherjee, Urmi Chatterji, Partha Roy
Formatua: Artikulua
Hizkuntza:English
Argitaratua: Taylor & Francis Group 2020-01-01
Saila:Artificial Cells, Nanomedicine, and Biotechnology
Sarrera elektronikoa:https://www.tandfonline.com/doi/10.1080/21691401.2020.1850465